CENTRALIZED CARDIAC SAFETY DATA: LESSONS LEARNED FROM A TRIAL SPONSOR
50% of clinical trials still use paper to collect, store and analyse ECG data creating risks to both your compounds and patients. By centralizing your ECGs you can:
- Increase data accuracy
- Mitigate risks
- Protect compounds and patients
Download this case study to see how centralization helped a trial sponsor when the FDA requested archived ECG data years after the study ended.
TALK TO ONE OF OUR CARDIAC SAFETY SPECIALISTS
Our team of experts is always available to provide consultation on your compound’s cardiac safety and the best, most cost-effective path forward to approval. Submit your contact information, and we’ll be in touch to schedule a meeting.